Shandong ORMA Pharmaceutical Co., Limited, info@ormapharma. com, can supply Afatinib, 439081-18-2, 850140-72-6; Alectinib, 1256580-46-7; Apatinib, 811803-05-1; Axitinib, 319460-85-0; Bafetinib, 887650-05-7, 859217-05-3, 859212-16-1; Bosutinib, 380843-75-4; Brivanib, 649735-46-6; Brivanib alaninate, 649735-63-7; Cabozantinib, 849217-68-1; Canertinib, 267243-28-7; Canertinib dihydrochloride, 289499-45-2; Cedirannib, 557795-03-6; Cediranib, 288383-20-0; Crizotinib, 877399-52-5; Crizotinib hydrochloride, 1415560-69-8; Dabrafenib, 1195765-45-7; Dacomitinib, 1110813-31-4; Dasatinib, 302962-49-8; Dovitinib, 405169-16-6; Dovitinib lactate, 915769-50-5, 804551-71-1; Erlotinib, 183321-74-6; Erlotinib hydrochloride, 183319-69-9; Filgotinib, 1206161-97-8; Gefitinib, 184475-35-2; Ibrutinib, 936563-96-1; Idelalisib, 870281-82-6, 1146702-54-6; Imatinib, 152459-95-5; Imatinib Mesylate, 220127-57-1; Lapatinib, 231277-92-2; Lapatinib Ditosylate, 388082-78-8, 388082-77-7; Masitinib, 790299-79-5; Mu
|
|
|